![]()
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
D. M. Brown
and Others
- 5 Oct, 2006
This
PowerPoint Slide Set is a value
added service that requires an individual subscription.
Already a print subscriber? Activate your online access
Not a Subscriber?
Get full access to NEJM Online now with a FREE TRIAL!
Or, purchase full access to this
PowerPoint Slide Set for $10